Lymphoblastic Lymphoma

Lymphoblastic Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Standard

Lymphoblastic Lymphoma : Guidelines From the International Lymphoma Radiation Oncology Group (ILROG). / Dabaja, Bouthaina Shbib; Specht, Lena; Yahalom, Joachim.

I: International Journal of Radiation Oncology, Biology, Physics, Bind 102, Nr. 3, 2018, s. 508-514.

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Harvard

Dabaja, BS, Specht, L & Yahalom, J 2018, 'Lymphoblastic Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)', International Journal of Radiation Oncology, Biology, Physics, bind 102, nr. 3, s. 508-514. https://doi.org/10.1016/j.ijrobp.2018.05.078

APA

Dabaja, B. S., Specht, L., & Yahalom, J. (2018). Lymphoblastic Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group (ILROG). International Journal of Radiation Oncology, Biology, Physics, 102(3), 508-514. https://doi.org/10.1016/j.ijrobp.2018.05.078

Vancouver

Dabaja BS, Specht L, Yahalom J. Lymphoblastic Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group (ILROG). International Journal of Radiation Oncology, Biology, Physics. 2018;102(3):508-514. https://doi.org/10.1016/j.ijrobp.2018.05.078

Author

Dabaja, Bouthaina Shbib ; Specht, Lena ; Yahalom, Joachim. / Lymphoblastic Lymphoma : Guidelines From the International Lymphoma Radiation Oncology Group (ILROG). I: International Journal of Radiation Oncology, Biology, Physics. 2018 ; Bind 102, Nr. 3. s. 508-514.

Bibtex

@article{0cd600f3d88b4ec7b313b35d9e5d7291,

title = "Lymphoblastic Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)",

abstract = "Presentation with a large mediastinal mass is a hallmark of acute lymphoblastic lymphoma, a disease that is treated in the same way as acute lymphoblastic leukemia even in the absence of marrow involvement. The role of mediastinal radiation for patients who achieve complete remission after chemotherapy has been overlooked and controversial. This document presents current knowledge on the role of radiation for lymphoblastic lymphoma and best practices for addressing how to deliver mediastinal radiation with modern technology.",

keywords = "Combined Modality Therapy, Computer Simulation, Humans, International Cooperation, Mediastinum/radiation effects, Motion, Practice Guidelines as Topic, Precursor Cell Lymphoblastic Leukemia-Lymphoma/radiotherapy, Radiation Oncology/methods, Radiotherapy Planning, Computer-Assisted, Radiotherapy, Intensity-Modulated, Remission Induction, Societies, Medical, Tomography, X-Ray Computed",

author = "Dabaja, {Bouthaina Shbib} and Lena Specht and Joachim Yahalom",

year = "2018",

doi = "10.1016/j.ijrobp.2018.05.078",

language = "English",

volume = "102",

pages = "508--514",

journal = "International Journal of Radiation Oncology, Biology, Physics",

issn = "0360-3016",

publisher = "Elsevier",

number = "3",

}

RIS

TY - JOUR

T1 - Lymphoblastic Lymphoma

T2 - Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)

AU - Dabaja, Bouthaina Shbib

AU - Specht, Lena

AU - Yahalom, Joachim

PY - 2018

Y1 - 2018

N2 - Presentation with a large mediastinal mass is a hallmark of acute lymphoblastic lymphoma, a disease that is treated in the same way as acute lymphoblastic leukemia even in the absence of marrow involvement. The role of mediastinal radiation for patients who achieve complete remission after chemotherapy has been overlooked and controversial. This document presents current knowledge on the role of radiation for lymphoblastic lymphoma and best practices for addressing how to deliver mediastinal radiation with modern technology.

AB - Presentation with a large mediastinal mass is a hallmark of acute lymphoblastic lymphoma, a disease that is treated in the same way as acute lymphoblastic leukemia even in the absence of marrow involvement. The role of mediastinal radiation for patients who achieve complete remission after chemotherapy has been overlooked and controversial. This document presents current knowledge on the role of radiation for lymphoblastic lymphoma and best practices for addressing how to deliver mediastinal radiation with modern technology.

KW - Combined Modality Therapy

KW - Computer Simulation

KW - Humans

KW - International Cooperation

KW - Mediastinum/radiation effects

KW - Motion

KW - Practice Guidelines as Topic

KW - Precursor Cell Lymphoblastic Leukemia-Lymphoma/radiotherapy

KW - Radiation Oncology/methods

KW - Radiotherapy Planning, Computer-Assisted

KW - Radiotherapy, Intensity-Modulated

KW - Remission Induction

KW - Societies, Medical

KW - Tomography, X-Ray Computed

U2 - 10.1016/j.ijrobp.2018.05.078

DO - 10.1016/j.ijrobp.2018.05.078

M3 - Review

C2 - 30238900

VL - 102

SP - 508

EP - 514

JO - International Journal of Radiation Oncology, Biology, Physics

JF - International Journal of Radiation Oncology, Biology, Physics

SN - 0360-3016

IS - 3

ER -

ID: 220862600